/Investor DB

DAYLI Partners — Full Portfolio

119 tracked investments · listed companies and verified rows first

Trinity Biotechtrinitybiotech.comNASDAQ: TRIB

Trinity Biotech develops and manufactures diagnostic products for the medical diagnostics market, selling directly in the United States and through international distributors and strategic partners in over 100 countries.

BiotechHealthtechMedical Devices

42Maru42maru.aiin𝕏Dec 2017

42Maru develops AI-powered question-answering and search technology that helps enterprises and application providers extract insights from large unstructured datasets.

AI & Machine LearningEnterprise SoftwareIoTRoboticsSaaSSeoul, KR

Co-investorsTechstarsDSC Investment

Aldaveraldaver.co.krDec 2024

Korean startup making biopolymer-based artificial organs for medical device testing and surgical training simulators.

Steve Park(Founder)in

Co-investorsAscendo VenturesKB InvestmentKorea Investment Partners

Alodokteralodokter.comin𝕏

Alodokter runs an Indonesian health platform that combines medical reference articles with direct chat access to licensed doctors.

Healthtech

Suci Arumsari(Founder)inNathanael Faibis(Founder)in

Co-investors500 GlobalGolden Gate VenturesWessel ManagementMDI VenturesSamsung Ventures

Arum Therapeuticsarumtherapeutics.com

Arum Therapeutics is a biotechnology company developing therapeutics, with a research-focused pipeline.

Biotech

Mark Taegon Baik(Founder)inTaegon Baik(Management)Ha-Young Lee(Management)

Co-investorsAju IB InvestmentSBI Investment Korea Co. Ltd.

BreezeBiobreezebio.comin𝕏Feb 2026

BreezeBio develops a programmable platform called NanoGalaxy for targeted delivery of genetic medicines, aiming to move genetic payloads to specific cells and tissues.

BiotechDeep TechLongevity

Co-investorsACVC PartnersDCVC (Data Collective)Kiwoom InvestmentSequoia CapitalDSC InvestmentKorea Investment Partners+3 more

Carus Biocarusbio.com

CARUS Bio develops gene delivery systems and cell-derived biologics for therapeutic applications.

BiotechDeep TechHealthtechMedical DevicesSeoul, KR

신규 배

Circumventcircumventpharmaceuticals.cominSeed

Circumvent develops precision medicines for neurodegenerative diseases, with current focus on Batten Disease and other rare neurological disorders.

BiotechDigital HealthHealthtechMedical DevicesPortland, US

Devin Wiley(Chief Medical Officer and Head of R\u0026D)inAndrew Lim(CEO)

Co-investorsY CombinatorStanford UniversityWestern Technology Investment

CMES Roboticscmesrobotics.ai

CMES Robotics builds AI-powered robotics systems that combine 3D vision and a proprietary AI core to inspect products, recognize objects, plan robot paths, and perform automated handling and manufacturing tasks.

Advanced ManufacturingAI & Machine LearningRobotics

Co-investorsAtinum Investment Co. Ltd.Kiwoom Investment

D&D Pharmatechddpharmatech.cominJun 2025

DD Pharmatech develops therapeutics for metabolic disorders, with a focus on oral and long-acting GLP-1 receptor agonist formulations.

Biotech

Seulki Lee(Executive Officer, Director)inSunghoon Hong(Executive Officer, Director)Sungmook Lim(Executive Officer, Director)

BoardDaehyun Shin(Director)Seungwon Lim(Director)Seol-Heui Han(Director)

Co-investorsKiwoom InvestmentLB InvestmentMagna InvestmentOctave Ventures Llc

Enclonyenclony.comin

Enclony builds high-speed vision inspection systems for pharmaceutical manufacturing, used to inspect tablets, capsules, and tablet-capsule hybrids and to verify laser marking.

Advanced ManufacturingAI & Machine LearningHardwareHealthtechMedical Devices

Co-investorsAju IB Investment

G2Gbiog2gbio.com

G2GBIO (Good to the Globe Biotech) is a pharmaceutical company developing improved new drug injectable formulations, with platform technology applicable to treatments for various diseases and mass-production techniques.

BiotechMedical Devices

Co-investorsAtinum Investment Co. Ltd.Magna InvestmentKorea Investment Partners

Genoplangenoplan.cominMar 2016

BiotechNew York, US

Byungkyu Kang(Executive Officer, Director, Promoter)in

Co-investorsSpark Labs Korea Accelerator Fund 4SBVASparkLabs Global VenturesSparkLabs Korea

Hyperfine Researchhyperfinemri.comin𝕏

Hyperfine develops the Swoop portable, point-of-care MRI system for brain imaging without ionizing radiation, used in clinical and research settings for infants, children, and adults.

AI & Machine LearningDigital HealthHealthtechMedical Devices

Jonathan Rothberg(Founder)in

Co-investorsDolby Family VenturesGV (Google Ventures)

IDienceidience.com

Idience is a biopharmaceutical company focused on developing and commercializing new medicines.

BiotechDigital HealthHealthtech

Won Sik Lee(Chief Executive Officer)inKyoung Soo Ha(Chief Medical Officer)Eun Kyung Kang(Chief Regulatory and Quality Officer)

Co-investorsKiwoom Investment

iN Therapeuticsintherapeutics.com

South Korean biotech developing small-molecule ion channel drugs, led by Nav1.7 inhibitors for pain and Kv7 modulators for CNS disorders.

Co-investorsAju IB InvestmentKiwoom Investment

Intocellintocell.com

South Korean biotech in Daejeon developing OHPAS linker and payload modification technologies for antibody drug conjugates.

Daejeon, KR

Co-investorsAF WPartnersAtinum Investment Co. Ltd.

Jeisysjeisys.comAcquired

Jeisys is a company focused on aesthetic and medical treatment products, presenting itself as a global provider open to partnerships and product inquiries.

HealthtechMedical DevicesSeoul, KR

Dong Hwan Kang(Chairman of Jeisys Medical)inRami Lee(CEO of Jeisys Medical)in

Co-investorsAtinum Investment Co. Ltd.We Ventures

Medipixelmedipixel.ioin

Medipixel develops AI-based clinical solutions in the medical technology field, working with hospitals and healthcare partners.

AI & Machine LearningDigital HealthMedical Devices

Co-investorsAscendo VenturesCompany K PartnersMirae Asset Venture InvestmentPremier PartnersAI Angel ClubAscendo Ventures

Neuroxtneuroxt.co.kr

NeuroXT develops MRI-based AI software that predicts amyloid and tau burden to guide Alzheimer's disease treatment decisions.

Co-investorsKakao VenturesAju IB InvestmentSmilegate Investment

Nrisenrise.netin

NRISE operates consumer mobile services including Wippy, a social dating/matching app connecting men and women in their 20s-30s in Korea and Japan, and Quat, a home-training fitness subscription app.

ConsumerSocialWellness & Fitness

Kim Dae-geun(CTO)

Co-investorsColopl NextLB Investment

ROKIT Healthcarerokithealthcare.comin

Healthcare company that recently went public.

Co-investorsAF WPartnersAscendo VenturesNH Investment & SecuritiesOasisPAG Japan

SkinGrabskingrab.co.kr

SKINGRAB is a South Korean manufacturer of energy-based aesthetic medical devices, including its FINIFF system, aimed at skincare professionals and patients.

HardwareHealthtechMedical Devices

Snviasnvia.kr

SNVIA is a South Korean Pusan National University spin-off developing embeddable microneedle patches and therapeutic polymers.

Co-investorsColopl Next

Tomocubetomocube.com

Tomocube develops holotomography (HT), a label-free, non-invasive 3D microscopic imaging technology that combines with AI to visualize and quantify live cells, organoids, and tissue samples.

AI & Machine LearningBiotechHardware

Vaxcell Biovaxcell-bio.comin

VaxcellBio develops anti-cancer immunotherapies, including NK cell therapies, CAR cell therapies, targeted anti-cancer agents, and antibody treatments for cancers such as liver, small-cell lung, pancreatic, solid, and blood cancers.

BiotechHealthtechMedical Devices

Co-investorsAju IB InvestmentLB Investment

Y-Biologicsybiologics.com

Y-Biologics (와이바이오로직스) develops antibody-based drugs using its antibody discovery, fully human antibody library, and antibody engineering technologies, working through its own pipeline and partner collaborations.

AI & Machine LearningBiotechHealthtechMedical DevicesDaejeon, KR

Co-investorsAju IB InvestmentIMM Investment JapanKiwoom InvestmentMagna InvestmentPearl Abyss Capital

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

1ST Biotherapeutics3D MedivisionAbClonAM ScienceAngel RoboticsAnterogenAston ScienceATsenseAUTOTAC BioBeamworksBiOrchestraBreeze BioCareNationCasCure TherapeuticsCdmoGenCellemedyCellidCelloramCharmacistCuraumCuriox BiosystemsCytoDxDAAN BiotherapeuticsDeepCardioDoctor DiaryDoctor NowDreamtechElgen TherapeuticselisiGenEnsol BiosciencesEutilexExosome PlusFNCT BiotechG2EGaluxGencellmedGenomictreeGI CellGI InnovationHuinnoHuons MeditechHysensBioIBEX Medical SystemsIllimis TherapeuticsJD BioscienceKanaph TherapeuticsKCell BiosciencesKey Prime ResearchLaSemillaLigachem BioscienceLive Cell InstrumentsLynk SolutecMalgeunaeilMaster MeditechMedifabMediOgenMeditrixMicrodigitalMthera PharmaMXT BiotechNextGen BioscienceNoulNovelty nobilityNuvi LabOn Us Link ItOnnuri StoreOptichoOrum TherapeuticsPantilogosPhantomicsPharmCADDPhASTPrecision BioPrimoris TherapeuticsProtium ScienceRanelaghRegen InnopharmRevosketchRibo TechSCM LifescienceSeaWithSL TherapeuticsSNBioscienceSpace FSugen TechT&R BiofabTENESTherapexTxinno BioscienceUbix TherapeuticsVIGENCELLWSG

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.